Dr. Farsad Afshinnia is Associate Professor of Medicine at the University of Michigan. He is trained in Internal Medicine and Nephrology. His clinical responsibilities include ICU and general nephrology care in inpatient and outpatient settings. His research focuses are on understanding metabolic risk determinants of progression of chronic kidney disease (CKD), and identification of prognostic metabolites predicting CKD progression using multiomics platforms in established CKD cohorts with and without diabetes. To that end the impact of novel biomarkers in risk stratification and early diagnosis, besides their impact on renal and cardiovascular outcomes beyond currently used traditional biomarkers are under investigation.